Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic acid for reduction of serum bilirubin in neonates with prolonged jaundice
IRCT20180228038895N2Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- May 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ursodeoxycholic acid in jaundice, sponsored by Guilan University of Medical Sciences. Primary endpoint: Change in serum bilirubin level. Started May 2023; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
jaundice
Beyond the preview
Go deeper on IRCT20180228038895N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180228038895N2.